Cue Biopharma, Inc. (CUE)
0.237
-0.01
(-2.63%)
USD |
NASDAQ |
Dec 24, 12:48
Cue Biopharma SG&A Expense (TTM): 16.81M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 631.20M |
| Puma Biotechnology, Inc. | 69.09M |
| Mersana Therapeutics, Inc. | 31.53M |
| Adaptive Biotechnologies Corp. | 162.86M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |